logo
  

Halma Plc Issues Trading Update - Quick Facts

Halma plc (HLMA.L) said its Board continues to expect adjusted profit before tax for fiscal 2021 to be 5%-10% below 2020 and more weighted to the second half than in previous years. Halma stated that it has delivered a resilient performance in line with the Board's expectations for the period from 1 April 2020 to date. The Group said its financial position remains robust, with committed facilities totalling approximately 750 million pounds at current exchange rates.

Halma plc also announced that Paul Walker has indicated his intention to retire from his role as Chair of Halma plc, and step down from the Board by July 2021. The Nomination Committee has established a process, led by Tony Rice, Senior Independent Director, to appoint a new Chair as his successor.

Paul Walker is to be appointed as Chair of RELX PLC during the first half of 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's top-selling drug Humira or adalimumab. Cyltezo, originally approved in August 2017, is both biosimilar to, and interchangeable with Humira for Cyltezo's approved uses. The Food and Drug Administration may be planning to allow people to receive Covid-19 vaccine booster shot that is different from the initial dose, reports indicate. The agency is likely to make the announcement on mix and match approach on coronavirus booster vaccines on Wednesday. The move will be part of FDA's expected authorization of boosters for the Moderna and Johnson & Johnson vaccines. Drug major Johnson & Johnson on Tuesday raised again its forecast for fiscal 2021 earnings and sales, which are above market view, after reporting higher results in the third quarter. The company's quarterly adjusted earnings also beat market estimates. In pre-market activity on the NYSE, JNJ shares were gaining around 1.24 percent to trade at $162.10.
RELATED NEWS
Follow RTT